Reports and Intelligence: China Cardiovascular Drugs Market - Size, Share, Global Trends, Company Profiles, Demand, Insights 2014-2018

1
Research on China Cardiovascular Drugs Industry,
2014-2018
Published on May 2014 No. of Pages 85
Reports and Intelligence
2
Description
Research on China Cardiovascular Drugs Industry,
2014-2018 primarily carries on analyses on
cardiovascular drugs market in the following
aspects market scale, the scale of segment
markets, current competition status and business
performance of major drug manufacturers
meanwhile it makes predictions about prospective
market so as to help investors know this industry
well and provide decision-making references for
them. With the aged tendency of population in
China and the increasing morbidity of chronic
diseases which have to be treated with medicines
for the rest of patients life, market scale of
cardiovascular drugs is expanding. This trend has
been reflected in recent years. While in the next
few years, with the reform of medical insurance
in China and the continuous standardization of
pharmaceutical market as well as the unique
curative effect of Chinese patent medicines,
Chinese patents medicines for cardiovascular
diseases will enjoy a promising development
prospect. 
3
Description
In 2013 market scale of cardiovascular drugs has
reached CNY 17.8 billion in China. At present
cardiovascular diseases have a relatively higher
morbidity rate among all diseases and also is a
kind of disease that is hard to be cured. Along
with the changes of peoples life-styles, the
difficulties in curing cardiovascular diseases
are becoming more prominent. The compound annual
growth rate of cardiovascular diseases is 21.6,
and the prevalence rate of cardiovascular
diseases will increase further because of the
improvements on peoples living standards, the
changes of life styles and increasing aging
population. The market will be expanded. On the
other hand, patients with cardiovascular diseases
have stood at 290 million, and patients with
chronic diseases who have received systematic
treatment account for a small proportion. In the
next ten years, there is a potential for the
growth in cardiovascular diseases treatment
field. It is predicted that the growth rate will
maintain more than 20 from 2014 to 2018. Huidian
Research estimates that the sales scale of
cardiovascular drugs in China in 2014 will reach
about CNY 22 billion, and the figure will be CNY
45 billion by 2018. 
4
Table Of Content

• Overview of China Cardiovascular Drugs Industry
• Development Environment of China Cardiovascular
  Drugs Industry
•  
• Development Status of Pharmaceuticals Industry
• Current Situation of Cardiovascular Drugs Market
• Competitive Analysis of China Cardiovascular 7
  Drugs
• Competitive Analysis of Chinese Patent Medicines
  for Cardiovascular System
• Leading Enterprises of Cardiovascular Drugs
  Industry
• Get full TOC at http//www.reportsandintelligence
  .com/research-on-china-cardiovascular-drugs-indust
  ry-2014-2018-market/table-of-contents

5
Get access to detailed information at
http//www.reportsandintelligence.com/research-on-
china-cardiovascular-drugs-industry-2014-2018-mark
et Request for Discount at http//www.reportsa
ndintelligence.com/purchase-enquiry/114266